Kyverna Therapeutics, Inc.KYTXNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-125.20M
↓ 111% below average
Average (3y)
$-59.30M
Historical baseline
Range
High:$-25.76M
Low:$-125.20M
CAGR
+69.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-125.20M | -114.1% |
| 2023 | $-58.47M | -110.5% |
| 2022 | $-27.78M | -7.8% |
| 2021 | $-25.76M | - |